PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the CD36-targeting immunotherapy.

Liver cancer often develops in individuals with chronic liver disease, with hepatocellular carcinoma (HCC) and cholangiocarcinoma as the main types. HCC is commonly associated with hepatitis B or C, ...

Two critical changes in your toilet habits could be a sign of a deadly cancer that is on the rise in Britain. Bile duct cancer, medically known as cholangiocarcinoma, is a cancer that grows in tubes ...

Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the scientific journal ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer, making up more than 80% of cases worldwide. It’s the sixth most common cancer and the third leading cause of cancer-related ...

Cancer of the liver, seen in a radial cross-section abdominal scan. (Photo by: BSIP/Universal Images Group via Getty Images) The number of new liver cancer cases will nearly double in the next 25 ...

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples ...